Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

Presentation ESC 2021

Continuing versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers:Impact on Adverse Outcomes in Hospitalized Patients with Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2

Presenter: Renato D. Lopes

August 30, 2021

News Conference News ESC 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Shelley Wood

August 28, 2021

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

L.A. McKeown

August 20, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

COVID-19: TCTMD’s Daily Dispatch for April Week 5

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March Week 5

Shelley Wood

March 29, 2021

News Daily News

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Michael O'Riordan

March 16, 2021

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

Advertisement

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Continuing versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers:Impact on Adverse Outcomes in Hospitalized Patients with Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

COVID-19: TCTMD’s Daily Dispatch for March Week 5

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

January 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content